Your Location:
Home >
Browse articles >
Shenqi Yiliu Prescription Reverses Cisplatin Resistance in Ovarian Cancer Cells by Regulating PI3K/Akt/mTOR Signaling Pathway-mediated Glycolysis
Shenqi Yiliu Prescription Reverses Cisplatin Resistance in Ovarian Cancer Cells by Regulating PI3K/Akt/mTOR Signaling Pathway-mediated Glycolysis
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 4, Pages: 60-69(2026)
DOI: 10.13422/j.cnki.syfjx.20251121
Revised:2025-03-12 ,
Accepted:14 March 2025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 4 ) Tabs( 7 )
References
Publication Info
Metrics
235
Views
141
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
Molecular Mechanism of Gypenoside L in Anti-Ovarian Cancer by Affecting GCK-Mediated Glycolytic Pathway
Mechanism of Modified Si Junzitang and Shashen Maidong Tang in Improving Sensitivity of Cisplatin in EGFR-TKI Resistant Lung Adenocarcinoma Cells Based on Aerobic Glycolysis
Research Progress of Traditional Chinese Medicine in Improving Diabetic Retinopathy Based on Nrf2 Signaling Pathway
Mechanism of Xixintang in Protecting Blood-brain Barrier in Alzheimer's Disease Model Rats Based on AQP4 Polarization
Related Author
YANG Ying
ZHAO Jiao
SUN Xiaofei
WANG Jiaxin
CUI Peng
SONG Nan
DONG Yuanguang
SONG Nan
Related Institution
Liaoning University of Traditional Chinese Medicine
Liaoning Cancer Hospital
Liaoning University of Traditional Chinese Medicine(TCM)
Liaoning Provincial Hospital of TCM
Longhua Hospital,Shanghai University of Traditional Chinese Medicine


